RxDoctor Payments Data

Sangmin Lee

Hematology & Oncology · New York, NYNPI 1144423237

Payments from drug & device makers

$921,028in general payments, 2019–2025

Across 63 payments — averaging $14,619 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stemline Therapeutics Inc.$559K
  • Acerta Pharma LLC$256K
  • Janssen Research & Development, LLC$76K
  • Helsinn Healthcare SA$9K
  • AstraZeneca$9K
  • Jazz Pharmaceuticals Inc.$7K
  • plus $5K from 10 others
$148,786in research payments, 2019–2025

Across 6 payments — averaging $24,798 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orphai Therapeutics Inc.$139K
  • Helsinn Healthcare SA$10K

What the payments were for

  • Consulting fees$21,18673%
  • Speaking & faculty fees$4001%
  • Travel & lodging$6,48722%
  • Food & beverage$8343%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$921,028 in reported general payments places this provider in the 85th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York

Other hematology & oncology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →